«Labyrinthitis

Below is an extended Labyrinthitis patents listing. Click here to return to the Labyrinthitis main in depth entry.

Patents :
US Patent No.	Title
6326901	Tactile communication device and method
6753164	Nucleic acids encoding human serpin polypeptide HMCIS41
6770466	Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
6861227	Antibodies to cytokine receptor common gamma chain like
6878806	Human secreted protein HTEEB42
6905688	Albumin fusion proteins
6919433	Antibodies to protein HPMBQ91
6926898	Albumin fusion proteins
6927204	Treatment of inner ear hair cells
6946134	Albumin fusion proteins
6951924	Antibodies against secreted protein HTEBYII
6693077	Keratinocyte growth factor-2
6653279	Treatment of inner ear hair cells
6627405	53BP2 complexes
6331537	Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
6333352	Method of treating benign positional vertigo
6362227	Methods for the treatment of tinnitus and other disorders using R(-)ketoptofen
6383150	Network-based system for diagnosing balance disorders
6429191	Treatment of hearing impairments
6429196	Treatment of balance impairments
6448283	Methods for preventing/treating damage to sensory hair cells and cochlear neurons
6551575	Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity
6593290	Treatment of inner ear hair cells
6620851	Methods for the treatment of neuropathic pain and other disorders using R(-)-ketoprofen
6974798	Treatment of balance impairments
6974823	Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
7247714	Protection against oxidative stress and inflammation by a cytoprotective response element
7253169	Aza compounds, pharmaceutical compositions and methods of use
7311958	Padded corner covers
7338936	Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7375192	Antibodies that specifically bind to chemokine beta-4
7378080	Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity
7381800	Antibodies to HBIMF63 polypeptide
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7238667	Albumin fusion proteins
7238660	Albumin fusion proteins
7232667	Keratinocyte growth factor-2 polynucleotides
6994857	Albumin fusion proteins
7026447	53 human secreted proteins
7091315	Protein HDPBQ71
7109302	Antibodies that specifically bind to GMAD
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7153883	Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
7163797	50 human secreted proteins
7175988	Human G-protein Chemokine Receptor (CCR5) HDGNR10
7189690	Albumin fusion proteins
7196164	Secreted protein HHTLF25
7411051	Antibodies to HDPPA04 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.